Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (UM1-AI110557)
National Institute of Neurological Disorders and Stroke (R01-NS080821)
National Institutes of Health (4T32HD007505-20)
Text and Data Mining valid from 2017-11-16
Received: 17 July 2017
Accepted: 3 October 2017
First Online: 16 November 2017
Compliance with ethical standards
: FHD and EAM have nothing to disclose. YMD has served as a consultant and/or received grant support from: Acorda, Bayer Pharmaceutical, Biogen Idec, EMD Serono, Genzyme, Novartis, Questor, Genentech, and Teva Neuroscience.
: This article does not contain any studies with human participants or animals performed by any of the authors.
: This is a review article about clinical trials in which the participants had informed consent. No identifying information was used in this article.